Moreover, blocking the expression of the PRNP gene using lentivector-mediated post-translational gene silencing mediated by RNA interference was shown to reduce neuronal PrPC expression, shedding new light on its potential use also in AD therapy [86]. Here, PRNP is linked to Alzheimer disease.